Labo Euromedis (STU:61R) Institutional Ownership: 1.99% (As of Aug. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:61R Labo Euromedis STU:61R
67 GF Score
Price €4.90
GF Value €4.38
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Labo Euromedis Institutional Ownership?

Labo Euromedis STU:61R -2.97% 67 Institutional Ownership is 1.99% as of Aug. 15, 2026. GuruFocus rates STU:61R with a GF Score™ of 67/100 and a GF Value™ of €4.38 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Labo Euromedis's institutional ownership is 1.99%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Labo Euromedis's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Labo Euromedis's Float Percentage Of Total Shares Outstanding is 0.00%.

Labo Euromedis Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Labo Euromedis's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labo Euromedis Institutional Ownership Chart

Labo Euromedis Historical Data

The historical data trend for Labo Euromedis can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 1.68 1.68 2.05 2.05 2.05 2.05 2.04 1.99 1.99 1.99
STU:61R
67GF Score
Labo Euromedis STU:61R
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Labo Euromedis Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 1.99% mean?
Labo Euromedis (STU:61R) has a Institutional Ownership of 1.99% as of Aug. 15, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Labo Euromedis and its competitors.
Is Labo Euromedis' Institutional Ownership too high?
Labo Euromedis' current Institutional Ownership is 1.99%. Overall, Labo Euromedis has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Labo Euromedis' Institutional Ownership compare to MCK and COR?
Labo Euromedis' Institutional Ownership of 1.99% can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Distribution company?
A good Institutional Ownership depends on the Medical Distribution industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Labo Euromedis and its competitors. Labo Euromedis's current Institutional Ownership is 1.99%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labo Euromedis stock overvalued right now?
Based on GuruFocus' analysis, Labo Euromedis (STU:61R) is currently considered Modestly Overvalued. The stock's GF Value™ is €4.38, compared to a current price of €4.90 — trading 11.9% above its estimated fair value. The current Institutional Ownership is 1.99%. Labo Euromedis' overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Labo Euromedis (STU:61R), the current Institutional Ownership is 1.99% as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Labo Euromedis (STU:61R) Overvalued in 2026?

Based on GuruFocus' analysis, Labo Euromedis stock appears to be overvalued. The current stock price of €4.90 is trading 11.9% above its estimated GF Value™ of €4.38. GuruFocus considers Labo Euromedis to be Modestly Overvalued.

Key valuation signals for STU:61R:

  • Institutional Ownership: 1.99%
  • GF Value™: €4.38 vs. price of €4.90 (11.9% above fair value)
  • GF Score™: 67/100 with 6 warning signs

No single metric tells the full story. See the STU:61R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Labo Euromedis Business Description

Other Exchanges 0I0L:UKALEMG:France
Address ZI de la Tuilerie, Neuilly-sous-Clermont, FRA, 60290
Labo Euromedis is engaged in medical devices. It is engaged in the design, manufacture, rental and export of medical and surgical equipment and products.
67GF Score

Get the complete analysis for STU:61R

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.90
Price
€4.38
GF Value